ISpecimen Correlations
| ISPC Stock | USD 0.31 0.02 6.90% |
The current 90-days correlation between iSpecimen and ENDRA Life Sciences is -0.29 (i.e., Very good diversification). The correlation of ISpecimen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
ISpecimen Correlation With Market
Weak diversification
The correlation between iSpecimen and DJI is 0.39 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding iSpecimen and DJI in the same portfolio, assuming nothing else is changed.
ISpecimen | Build AI portfolio with ISpecimen Stock |
Moving together with ISpecimen Stock
| 0.71 | PG | Procter Gamble | PairCorr |
| 0.82 | HPQ | HP Inc | PairCorr |
| 0.87 | HD | Home Depot Sell-off Trend | PairCorr |
| 0.88 | MSFT | Microsoft | PairCorr |
Moving against ISpecimen Stock
| 0.87 | CSCO | Cisco Systems | PairCorr |
| 0.87 | MRK | Merck Company Sell-off Trend | PairCorr |
| 0.86 | FTV | Fortive Corp | PairCorr |
| 0.81 | AMGN | Amgen Inc | PairCorr |
| 0.79 | CAT | Caterpillar | PairCorr |
| 0.78 | XOM | Exxon Mobil Corp | PairCorr |
| 0.78 | BAC | Bank of America Earnings Call This Week | PairCorr |
| 0.75 | AXP | American Express | PairCorr |
| 0.7 | TRV | The Travelers Companies | PairCorr |
| 0.68 | GILD | Gilead Sciences | PairCorr |
| 0.64 | KO | Coca Cola | PairCorr |
| 0.6 | MCD | McDonalds | PairCorr |
| 0.59 | JPM | JPMorgan Chase Earnings Call This Week | PairCorr |
| 0.43 | MMM | 3M Company | PairCorr |
| 0.43 | IBM | International Business | PairCorr |
Related Correlations Analysis
Risk-Adjusted Indicators
There is a big difference between ISpecimen Stock performing well and ISpecimen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ISpecimen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NDRA | 5.77 | 0.03 | 0.00 | 0.03 | 0.00 | 13.24 | 49.07 | |||
| TOVX | 8.31 | (0.13) | 0.00 | 0.02 | 10.65 | 20.00 | 139.72 | |||
| VTAK | 4.61 | (0.30) | 0.00 | (0.10) | 0.00 | 13.33 | 35.41 | |||
| HSCS | 3.72 | (0.24) | 0.00 | (0.14) | 0.00 | 10.47 | 26.18 | |||
| GLMD | 3.97 | (0.97) | 0.00 | (0.39) | 0.00 | 8.04 | 21.39 | |||
| BJDX | 5.98 | (0.70) | 0.00 | 1.90 | 0.00 | 10.19 | 87.65 | |||
| BIVI | 3.34 | (0.52) | 0.00 | (0.59) | 0.00 | 7.41 | 17.43 | |||
| BIAF | 4.82 | (0.98) | 0.00 | (1.60) | 0.00 | 9.55 | 39.96 | |||
| SHPH | 5.44 | (1.02) | 0.00 | (1.48) | 0.00 | 10.76 | 35.78 | |||
| ZCMD | 4.57 | (1.19) | 0.00 | (0.40) | 0.00 | 8.20 | 61.79 |
ISpecimen Corporate Management
| Emily Hubbard | VP Devel | Profile | |
| Benjamin Bielak | Chief Secretary | Profile | |
| Eric Langlois | Chief Officer | Profile | |
| Dawn Michelle | VP Operations | Profile | |
| Yuying Liang | Chief Officer | Profile | |
| Annette Arnold | Vice Development | Profile |